Company: SINT
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010496
Chunk: 28

Company: Sintx Technologies, Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Item 8
Chunk 28
---
 areas outside of spinal fusion
applications. For instance, results from an independent study demonstrated the potential anti-viral properties of our silicon
nitride.

On February 20, 2025, we entered
into a private placement transaction pursuant to a Securities Purchase Agreement (the “Purchase Agreement”) with certain
institutional and accredited investors for aggregate gross proceeds of $5.0 million, before deducting fees to the placement agent
and other expenses payable by us in connection with the Private Placement. We intend to use the net proceeds from
the Private Placement for general corporate purposes and working capital. H.C. Wainwright & Co. (“Wainwright”),
acted as the exclusive placement agent for the Private Placement, which closed on February 25, 2025. As part of the Private
Placement, we issued (i) 1,171,189 shares of our common stock, par value $0.01 per share (“Common
Stock”), (ii) pre-funded warrants to purchase 278,098 shares of Common Stock (the “Pre-Funded Warrants”) with an
exercise price of $0.0001 per share, and (iii) warrants to purchase 1,449,287 shares of Common Stock (the “Common
Warrants,” together with the Pre-Funded Warrants, the “Warrants”) (the Warrants, together with the Shares and
Warrant Shares (as defined below), the “Securities”) with an exercise price of $3.32 per share. The purchase price per
share of Common Stock and the associated Common Warrant was $3.45 and the purchase price per Pre-Funded Warrant and associated
Common Warrant was $3.4499. The Common Warrants are exercisable immediately and expire five-and one-half years from issuance. The
Pre-Funded Warrants are exercisable immediately and terminate when exercised in full.

On March 26, 2024, we closed a
public offering 142,000 shares of our common stock, (the “March 26 Offering”) at a public offering price of $9.40 per share. The
aggregate proceeds from the March 26 Offering were approximately $1.3 million before deducting placement agent fees
and other estimated offering expenses payable by us.

On April 5, 2024, we closed a public
offering of 358,000 shares of our common stock, (the “April 5 Offering”) at a public offering price of $4.20